Sign in

or Register now

MyRACentral.com

See all of our health sites at www.HealthCentral.com
Wednesday, November, 25, 2009
  • Font size
Receive a FREE Osteoarthritis of the knee pamphlet.  Start here.

Hydroxychloroquine May Reduce Risk of Type 2 Diabetes

Christine Miller
Christine Miller
Close

I was diagnosed as a toddler with JRA and since then have gone...

Christine Miller

Saturday, July 21, 2007
View All of Christine Miller's Posts
Researchers have found a link between hydroxychloroquine and a decreased risk of developing type-2 diabetes. Hydroxychloroquine has been in use for approximately 50 years. It was first developed as an anti-malaria drug, and then as treatment for rheumatoid arthritis, lupus and other rheumatic disease...
  1. PLAQUENIL
    SUE PRYOR
    Thursday, August 09, 2007 at 11:06 PM

    CAN A PERSON BECOME IMMUNE TO THIS DRUG AS EASY AS OTHERS? I HAVE FOUND AFTER TAKING ENBREL AND A FEW OTHER DRUGS FOR MY RA AFTER 4 YRS MY BODY DIDNT ACCEPT THE TREATMENT BUT THE PLAQUENIL KEEPS WORKING...WHY IS THIS..

    Reply
    re: PLAQUENIL
    Christine Miller
    Friday, August 17, 2007 at 11:28 AM
    I'm not sure why this is, except that Plaquenil was developed first as an anti-malaria drug. It would be a great question to send to Dr. Borgini. I have heard that people's bodies become used to anti-TNF inhibitors like Enbrel over time, requiring a higher dosage or change in medication.  The same thing happened to me with celebrex and naprosyn. 
    Reply
  • Font size
  • Bookmark
  • Was this helpful? Yes
  • Save
  • RSS
  • Report Abuse

Ask a Question

Get answers from our experts and community members.

View all questions (1963) >